BeEAM Versus CEM in Lymphoma Patients as a Conditioning Regimen Before Autologous Hematopoietic Cell Transplantation

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 11, 2022

Primary Completion Date

December 30, 2023

Study Completion Date

December 30, 2023

Conditions

Lymphoma

Interventions

DRUG

BEAM Protocol

BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan)

DRUG

CEM protocol

CEM (Carboplatin, Etoposide, Melphalan)

Trial Locations (1)

International Medical Center (IMC) Hospital, Cairo, Egypt., Cairo

All Listed Sponsors

lead

Rehab Werida

OTHER